赛隆药业集团股份有限公司关于持股5%以上股东部分股份质押的公告

Core Viewpoint - The announcement details the pledge of shares by a major shareholder, Cai Nanguai, which exceeds 80% of his holdings, raising potential concerns for investors regarding the company's financial stability and governance [1][8]. Shareholder Pledge Basic Situation - Cai Nanguai holds 67,512,703 shares, making him the largest shareholder but not the controlling shareholder. He has signed a commitment to waive voting rights on his remaining shares [1]. - The pledged shares do not involve any major asset restructuring or performance compensation obligations [1]. Cumulative Pledge Situation - As of the announcement date, the pledged shares include those of Cai Nanguai and his concerted actions, with specific details on the number of shares pledged and their status [2]. Financing and Use of Pledged Shares - Part of the financing from the pledged shares will be used to provide loans to the company to support its operations, while the remainder is for personal funding needs [3][6]. - Cai Nanguai and his concerted actions have no upcoming pledge financing due within the next six months or one year, indicating a stable financial situation [3]. Risk Management and Control - Cai Nanguai's high proportion of pledged shares is primarily to support company development and personal funding needs. He has a good credit status and repayment capability, with no debt repayment risk [7]. - The company’s control has changed, but this will not affect its operations or governance [5][8]. Guarantees and Loans - Cai Nanguai has provided guarantees for credit limits totaling 60 million yuan to banks, with no counter-guarantees from the company or its subsidiaries, incurring no related costs [7]. - He has also provided loans to the company up to 160 million yuan at an annual interest rate of 3.0%, calculated based on actual borrowing amounts and days used [7].